Trial Profile
Effects of dexmedetomidine on preventing sleep disturbance and delirium during high flow oxygen therapy in patients with acute respiratory failure.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Nov 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 14 Nov 2019 Status changed from recruiting to completed.
- 14 Nov 2018 Status changed from not yet recruiting to recruiting.
- 06 Feb 2015 New trial record